Concepedia

D-W Kim

DK

7

Publications

1.6K

Citations

7

H-Index

2008

Active since

Affiliations

Catholic University of Korea(Current)

The University of Texas MD Anderson Cancer Center

The Catholic University of Korea Seoul St. Mary's Hospital

Heidelberg University

South Australia Pathology

D-W Kim is an author at Catholic University of Korea specializing in oncology, hematology, and medicine.

Top concepts

Publications per year

2008–2016

7

Publications

7

Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Andreas Hochhaus, Giuseppe Saglio, Timothy P. Hughes et al. · Leukemia · 2016 · 841 citations · Full text

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study

Francis J. Giles, Philipp D. le Coutre, Javier Pinilla‐Ibarz et al. · Leukemia · 2012 · 246 citations

, , +6

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

Jörge E. Cortes, D-W Kim, Emmanuel Raffoux et al. · Leukemia · 2008 · 198 citations

, , +6

Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy

Francis J. Giles, Elisabetta Abruzzese, Gianantonio Rosti et al. · Leukemia · 2010 · 115 citations

, , +8

BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase

Timothy P. Hughes, Giuseppe Saglio, Alfonso Quintás‐Cardama et al. · Leukemia · 2015 · 71 citations · Full text

, , +15

Rows per page

1–5 of 7